ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.

Thomas Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.